SANOFI CONS HEALTHC IND L - Asset Resilience Ratio

Latest as of December 2025: 0.07%

SANOFI CONS HEALTHC IND L (SANOFICONR) has an Asset Resilience Ratio of 0.07% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read SANOFICONR total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets

Rs4.00 Million
≈ $43.26K USD Cash + Short-term Investments

Total Assets

Rs5.47 Billion
≈ $59.16 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2024–2025)

This chart shows how SANOFI CONS HEALTHC IND L's Asset Resilience Ratio has changed over time. See SANOFICONR book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down SANOFI CONS HEALTHC IND L's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see SANOFI CONS HEALTHC IND L (SANOFICONR) total market value.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rs0.00 0%
Short-term Investments Rs4.00 Million 0.07%
Total Liquid Assets Rs4.00 Million 0.07%

Asset Resilience Insights

  • Limited Liquidity: SANOFI CONS HEALTHC IND L maintains only 0.07% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

SANOFI CONS HEALTHC IND L Industry Peers by Asset Resilience Ratio

Compare SANOFI CONS HEALTHC IND L's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Pfizer Inc
SA:PFIZ34
Drug Manufacturers - General 7.18%
CSPC Pharmaceutical Group Limited
F:CVG
Drug Manufacturers - General 4.64%
Aurora Optoelectronics Co Ltd
SHG:600666
Drug Manufacturers - General 5.89%
Shandong Keyuan Pharmaceutical Co. Ltd. A
SHE:301281
Drug Manufacturers - General 6.44%
Dimed S.A. Distribuidora de Medicamentos
SA:PNVL3
Drug Manufacturers - General 10.10%
Pfizer Inc
NYSE:PFE
Drug Manufacturers - General 7.18%
Merck & Company Inc
NYSE:MRK
Drug Manufacturers - General 14.06%
Firebrick Pharma Ltd
AU:FRE
Drug Manufacturers - General 0.29%

Annual Asset Resilience Ratio for SANOFI CONS HEALTHC IND L (2024–2025)

The table below shows the annual Asset Resilience Ratio data for SANOFI CONS HEALTHC IND L.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 0.07% Rs4.00 Million
≈ $43.26K
Rs5.47 Billion
≈ $59.16 Million
-0.81pp
2024-12-31 0.88% Rs38.00 Million
≈ $410.96K
Rs4.31 Billion
≈ $46.64 Million
--
pp = percentage points

About SANOFI CONS HEALTHC IND L

NSE:SANOFICONR India Drug Manufacturers - General
Market Cap
$1.19 Billion
Rs109.72 Billion INR
Market Cap Rank
#8372 Global
#396 in India
Share Price
Rs4763.90
Change (1 day)
-0.51%
52-Week Range
Rs3999.50 - Rs5696.00
All Time High
Rs5696.00
About

Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. It offers products in the allergy, physical wellness, and pain care segments under brands, such as Allegra, Combiflam, Avil, DePURA, Festal, and Novalgin NU through distributors, wholesalers, government institutions and hospitals, pharmacies, pharmacy chains, and e-commerce. The company was in… Read more